Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Publications
(up to ten in the last five years)
Last Updated 6/5/2022
Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.
American Journal of Surgical Pathology
42 issue 2
Date: 02 2018
https://www.ncbi.nlm.nih.gov/pubmed/29076876
Inflammasome formation in the lungs of patients with fatal COVID-19
Inflammation Research
Volume: 70
Date: 01 2021
The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3
Nature Communications
Volume: 12
Date: 01 2021
Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization
Clinical Breast cancer
Volume: 21
Date: 10 2021
Minute Pulmonary Meningothelial-like Nodules.
Radiology Cardiothoracic Imaging
Volume: 3
Date: 10 2021
Flower lose, a cell fitness marker, predicts COVID-19 prognosis
EMBO Molecular Medicine
Volume: 13
Date: 11 2021
Usefulness of Cyclin D1/Podoplanin Dual Immunohistochemical Stain to Differentiate Malignant Mesothelioma From Reactive Mesothelial Proliferations
American Journal of Clinical Pathology
Date: 03 2022
//doi.org/10.1093/ajcp/aqac022
Caspase-9b drives cellular transformation, lung inflammation, and lung tumorigenesis
Molecular Cancer Research
Date: 04 2022
Too Sensitive or Just Right? A Comparison of Two ALK Antibodies (D5F3 and ALK1) for Assessment of Anaplastic Large Cell Lymphoma
American Journal of Clinical Pathology
Date: 04 2022
//doi.org/10.1093/ajcp/aqac043
Reliability of histopathologic diagnosis of fibrotic interstitial lung disease: an international collaborative standardization project
BMC Pulmonary Medicine
Volume: 21
Date: 06 2022